These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 21711065)

  • 1. Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.
    Grabner M; Onukwugha E; Jain R; Mullins CD
    J Oncol Pract; 2011 May; 7(3 Suppl):e16s-24s. PubMed ID: 21886506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and ethnic variation in health resource use and cost for prostate cancer.
    Jayadevappa R; Malkowicz SB; Chhatre S; Gallo J; Schwartz JS
    BJU Int; 2010 Sep; 106(6):801-8. PubMed ID: 20151963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Beinart SC; Kolm P; Veledar E; Zhang Z; Mahoney EM; Bouin O; Gabriel S; Jackson J; Chen R; Caro J; Steinhubl S; Topol E; Weintraub WS
    J Am Coll Cardiol; 2005 Sep; 46(5):761-9. PubMed ID: 16139122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
    Tunis SL
    Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer.
    Hillner BE; McLeod DG; Crawford ED; Bennett CL
    Urology; 1995 Apr; 45(4):633-40. PubMed ID: 7716844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
    Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
    Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group.
    Ng R; Hasan B; Mittmann N; Florescu M; Shepherd FA; Ding K; Butts CA; Cormier Y; Darling G; Goss GD; Inculet R; Seymour L; Winton TL; Evans WK; Leighl NB; ; ;
    J Clin Oncol; 2007 Jun; 25(16):2256-61. PubMed ID: 17538170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese.
    Xie F; Luo N; Blackhouse G; Goeree R; Lee HP
    Int J Technol Assess Health Care; 2008; 24(1):87-95. PubMed ID: 18218173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
    Tunis SL; Willis WD; Foos V
    Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials.
    Berg J; Lindgren P; Spiesser J; Parry D; Jönsson B
    Clin Ther; 2007 Jun; 29(6):1184-202. PubMed ID: 17692733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer.
    Penson DF; Ramsey S; Veenstra D; Clarke L; Gandhi S; Hirsch M
    J Urol; 2005 Aug; 174(2):547-52; discussion 552. PubMed ID: 16006889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incremental cost effectiveness of multifocal cataract surgery].
    Pagel N; Dick HB; Krummenauer F
    Klin Monbl Augenheilkd; 2007 Feb; 224(2):101-9. PubMed ID: 17309005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse probability weighted least squares regression in the analysis of time-censored cost data: an evaluation of the approach using SEER-Medicare.
    Griffiths RI; Gleeson ML; Danese MD; O'Hagan A
    Value Health; 2012; 15(5):656-63. PubMed ID: 22867774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A note on the estimation of confidence intervals for cost-effectiveness when costs and effects are censored.
    Blackhouse G; Briggs AH; O'Brien BJ
    Med Decis Making; 2002; 22(2):173-7. PubMed ID: 11958499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer.
    Vrdoljak E; Sekerija M; Plestina S; Belac Lovasic I; Katalinic Jankovic V; Garattini L; Bobinac A; Voncina L
    Eur J Health Econ; 2021 Apr; 22(3):393-403. PubMed ID: 33438133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Median-based incremental cost-effectiveness ratios with censored data.
    Bang H; Zhao H
    J Biopharm Stat; 2016; 26(3):552-64. PubMed ID: 26010599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Average cost-effectiveness ratio with censored data.
    Bang H; Zhao H
    J Biopharm Stat; 2012; 22(2):401-15. PubMed ID: 22251182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.
    Penson DF
    J Urol; 2012 Jul; 188(1):115. PubMed ID: 22682830
    [No Abstract]   [Full Text] [Related]  

  • 19. Racial variation in the cost-effectiveness of chemotherapy for prostate cancer.
    Grabner M; Onukwugha E; Jain R; Mullins CD
    Am J Manag Care; 2011 May; 17(5 Spec No):e151-9. PubMed ID: 21711065
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.